dr hart neurology limited Company Information
Company Number
07499318
Next Accounts
Dec 2025
Shareholders
jacqueline hart
paul edward hart
Group Structure
View All
Industry
General medical practice activities
Registered Address
7 - 9, the avenue, eastbourne, east sussex, BN21 3YA
Website
-dr hart neurology limited Estimated Valuation
Pomanda estimates the enterprise value of DR HART NEUROLOGY LIMITED at £970.6k based on a Turnover of £1.6m and 0.59x industry multiple (adjusted for size and gross margin).
dr hart neurology limited Estimated Valuation
Pomanda estimates the enterprise value of DR HART NEUROLOGY LIMITED at £867.3k based on an EBITDA of £191k and a 4.54x industry multiple (adjusted for size and gross margin).
dr hart neurology limited Estimated Valuation
Pomanda estimates the enterprise value of DR HART NEUROLOGY LIMITED at £2.1m based on Net Assets of £749.5k and 2.75x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr Hart Neurology Limited Overview
Dr Hart Neurology Limited is a live company located in eastbourne, BN21 3YA with a Companies House number of 07499318. It operates in the general medical practice activities sector, SIC Code 86210. Founded in January 2011, it's largest shareholder is jacqueline hart with a 75% stake. Dr Hart Neurology Limited is a established, small sized company, Pomanda has estimated its turnover at £1.6m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dr Hart Neurology Limited Health Check
Pomanda's financial health check has awarded Dr Hart Neurology Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs


3 Strong

4 Regular

4 Weak

Size
annual sales of £1.6m, make it in line with the average company (£1.9m)
- Dr Hart Neurology Limited
£1.9m - Industry AVG

Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (10.5%)
- Dr Hart Neurology Limited
10.5% - Industry AVG

Production
with a gross margin of 39.1%, this company has a comparable cost of product (39.1%)
- Dr Hart Neurology Limited
39.1% - Industry AVG

Profitability
an operating margin of 11.4% make it more profitable than the average company (3.6%)
- Dr Hart Neurology Limited
3.6% - Industry AVG

Employees
with 2 employees, this is below the industry average (24)
2 - Dr Hart Neurology Limited
24 - Industry AVG

Pay Structure
on an average salary of £34.5k, the company has an equivalent pay structure (£34.5k)
- Dr Hart Neurology Limited
£34.5k - Industry AVG

Efficiency
resulting in sales per employee of £817.5k, this is more efficient (£85.8k)
- Dr Hart Neurology Limited
£85.8k - Industry AVG

Debtor Days
it gets paid by customers after 68 days, this is later than average (31 days)
- Dr Hart Neurology Limited
31 days - Industry AVG

Creditor Days
its suppliers are paid after 5 days, this is quicker than average (25 days)
- Dr Hart Neurology Limited
25 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Dr Hart Neurology Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 40 weeks, this is average cash available to meet short term requirements (39 weeks)
40 weeks - Dr Hart Neurology Limited
39 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 19.6%, this is a lower level of debt than the average (56.4%)
19.6% - Dr Hart Neurology Limited
56.4% - Industry AVG
DR HART NEUROLOGY LIMITED financials

Dr Hart Neurology Limited's latest turnover from March 2024 is estimated at £1.6 million and the company has net assets of £749.5 thousand. According to their latest financial statements, Dr Hart Neurology Limited has 2 employees and maintains cash reserves of £139.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||
Other Income Or Grants | |||||||||||||
Cost Of Sales | |||||||||||||
Gross Profit | |||||||||||||
Admin Expenses | |||||||||||||
Operating Profit | |||||||||||||
Interest Payable | |||||||||||||
Interest Receivable | |||||||||||||
Pre-Tax Profit | |||||||||||||
Tax | |||||||||||||
Profit After Tax | |||||||||||||
Dividends Paid | |||||||||||||
Retained Profit | |||||||||||||
Employee Costs | |||||||||||||
Number Of Employees | 2 | 3 | 4 | 5 | 3 | 3 | 4 | 4 | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 13,674 | 16,743 | 5,564 | 6,398 | 8,530 | 11,375 | 9,287 | 10,813 | 13,909 | 11,239 | 1,355 | 1,124 | 108 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 13,674 | 16,743 | 5,564 | 6,398 | 8,530 | 11,375 | 9,287 | 10,813 | 13,909 | 11,239 | 1,355 | 1,124 | 108 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 309,021 | 211,587 | 43,224 | 479,594 | 350,098 | 235,920 | 212,547 | 199,548 | 178,242 | 46,682 | 51,607 | 53,432 | 61,701 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 5,960 | 921 | 883 | 856 | 848 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 139,889 | 142,167 | 183,383 | 0 | 0 | 0 | 0 | 0 | 0 | 187,588 | 192,888 | 319,135 | 193,701 |
misc current assets | 463,777 | 383,284 | 330,615 | 0 | 0 | 828 | 798 | 779 | 758 | 0 | 0 | 0 | 0 |
total current assets | 918,647 | 737,959 | 558,105 | 480,450 | 350,946 | 236,748 | 213,345 | 200,327 | 179,000 | 234,270 | 244,495 | 372,567 | 255,402 |
total assets | 932,321 | 754,702 | 563,669 | 486,848 | 359,476 | 248,123 | 222,632 | 211,140 | 192,909 | 245,509 | 245,850 | 373,691 | 255,510 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 14,895 | 17,062 | 1,997 | 102,910 | 104,552 | 85,010 | 81,635 | 72,304 | 63,825 | 74,585 | 64,461 | 61,073 | 58,017 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 166,594 | 129,648 | 103,858 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 181,489 | 146,710 | 105,855 | 102,910 | 104,552 | 85,010 | 81,635 | 72,304 | 63,825 | 74,585 | 64,461 | 61,073 | 58,017 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 1,381 | 4,186 | 936 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 1,381 | 4,186 | 936 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 182,870 | 150,896 | 106,791 | 102,910 | 104,552 | 85,010 | 81,635 | 72,304 | 63,825 | 74,585 | 64,461 | 61,073 | 58,017 |
net assets | 749,451 | 603,806 | 456,878 | 383,938 | 254,924 | 163,113 | 140,997 | 138,836 | 129,084 | 170,924 | 181,389 | 312,618 | 197,493 |
total shareholders funds | 749,451 | 603,806 | 456,878 | 383,938 | 254,924 | 163,113 | 140,997 | 138,836 | 129,084 | 170,924 | 181,389 | 312,618 | 197,493 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||
Operating Profit | |||||||||||||
Depreciation | 4,253 | 2,951 | 0 | 3,747 | 452 | 375 | 12 | ||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Tax | |||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 102,473 | 168,401 | -436,343 | 129,504 | 115,026 | 23,373 | 12,999 | 21,306 | 131,560 | -4,925 | -1,825 | -8,269 | 61,701 |
Creditors | -2,167 | 15,065 | -100,913 | -1,642 | 19,542 | 3,375 | 9,331 | 8,479 | -10,760 | 10,124 | 3,388 | 3,056 | 58,017 |
Accruals and Deferred Income | 36,946 | 25,790 | 103,858 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -2,805 | 3,250 | 936 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||
Investing Activities | |||||||||||||
capital expenditure | |||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||
Financing Activities | |||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||
interest | |||||||||||||
cash flow from financing | |||||||||||||
cash and cash equivalents | |||||||||||||
cash | -2,278 | -41,216 | 183,383 | 0 | 0 | 0 | 0 | 0 | -187,588 | -5,300 | -126,247 | 125,434 | 193,701 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -2,278 | -41,216 | 183,383 | 0 | 0 | 0 | 0 | 0 | -187,588 | -5,300 | -126,247 | 125,434 | 193,701 |
dr hart neurology limited Credit Report and Business Information
Dr Hart Neurology Limited Competitor Analysis

Perform a competitor analysis for dr hart neurology limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in BN21 area or any other competitors across 12 key performance metrics.
dr hart neurology limited Ownership
DR HART NEUROLOGY LIMITED group structure
Dr Hart Neurology Limited has no subsidiary companies.
Ultimate parent company
DR HART NEUROLOGY LIMITED
07499318
dr hart neurology limited directors
Dr Hart Neurology Limited currently has 2 directors. The longest serving directors include Mrs Jacqueline Hart (Jan 2011) and Dr Paul Hart (Jan 2011).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Jacqueline Hart | 57 years | Jan 2011 | - | Director | |
Dr Paul Hart | United Kingdom | 57 years | Jan 2011 | - | Director |
P&L
March 2024turnover
1.6m
+80%
operating profit
186.8k
0%
gross margin
39.2%
-4.15%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
749.5k
+0.24%
total assets
932.3k
+0.24%
cash
139.9k
-0.02%
net assets
Total assets minus all liabilities
dr hart neurology limited company details
company number
07499318
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
January 2011
age
14
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
7 - 9, the avenue, eastbourne, east sussex, BN21 3YA
Bank
-
Legal Advisor
-
dr hart neurology limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr hart neurology limited.
dr hart neurology limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DR HART NEUROLOGY LIMITED. This can take several minutes, an email will notify you when this has completed.
dr hart neurology limited Companies House Filings - See Documents
date | description | view/download |
---|